Sarah C. Charney
Adjunct Professor, Veterinary Clinical Medicine

Professional Interests:  My professional interests include clinical trials of new chemotherapy agents and protocols, as well as therapies for metastatic cancer.

Selected Publications

Bergman PJ, McKnight JA, Novosad CA, Charney SC, Farrelly J, Craft D, Riviere I, Wulderk M, Jeffers Y, Hohenhaus AE, Segal N, Gregor P, Englehorn M, Sadelian M, Houghton AN, Wolchuk JD. Long term survival of dogs with advanced malignant melanoma following DNA vaccination with xenogeneic human tyrosinase: Clinical Cancer Research 9: 1284-1290, April 2003.

Charney SC, Bergman PJ, Hohenhaus AE, McKnight JA. Risk factors for sterile hemorrhagic cystitis in dogs with lymphoma receiving cyclophosphamide with or without concurrent administration of furosemide: 216 cases (1990-1996).   J Am Vet Med Assoc 222:10 May 15, 2003, p. 1388-1393 .

Wiedemann AL, Charney SC, Barger AM, Schaeffer DJ, Kitchell BE.  Corticosteriod-induced alkaline phosphatase as a prognostic indicator for canine lymphoma. J Am Anim Hosp Assoc, submitted.

Fan TM, de Lorimier LP, Hintermeister JG, Goldberg TL, Jones PD, Wiedemann AL, Charney SC, Kitchell BE. Renal safety of adjuvant pamidronate in tumor-bearing dogs. J Am Anim Hosp Assoc, submitted.

Fan TM, de Lorimier LP, Charney SC. Aminobisphosphonates: Molecular mechanisms of action and potential therapeutic applications in veterinary oncology. Vet Cancer Soc Newletter, in print, 2004;27(4)1-6.

Charney SC, Fan TM, de Lorimier LP . Evaluating bone turnover markers and bone mineral density in pamidronate-treated dogs with appendicular osteosarcoma: preliminary results. Veterinary Cancer Society 23 rd Annual Conference, Madison WI, September 29 2003, p.65.

Endicott MM, Charney SC, McKnight JA, Bergman PJ.   Incidence of bone marrow infiltration and hematological abnormalities associated with marrow infiltration in canine cutaneous mast cell tumors.   Veterinary Cancer Society 23 rd Annual Conference, Madison WI, September 29 2003, p. 22.

Wiedeman AL, Charney SC, Barger AM, Schaeffer DJ, Kitchell BE.   Corticosteriod-induced alkaline phosphatase as a prognostic indicator for canine lymphoma. Veterinary Cancer Society 23 rd Annual Conference, Madison WI, September 29 2003, p.34.

Fan TM, de Lorimier LP, Charney SC. In vitro cytotoxic and cytostatic effects of pamidronate and zoledronate in three canine osteosarcoma cell lines. Veterinary Cancer Society 23 rd Annual Conference, Madison WI, September 29 2003, p.66.

de Lorimier LP, Fan TM, Charney SC. Evaluation of plasma levels of enbdothelin-1 (ET-1) in dogs with appendicular osteosarcoma. Veterinary Cancer Society 23 rd Annual Conference, Madison WI, September 29 2003, p.67.

Lacoste HI, Fan TM, de Lorimier LP, Charney SC, Thomas MC. Baseline urine N-telopeptide (NTx) concentrations in dogs with osteosarcoma. Veterinary Cancer Society 23 rd Annual Conference, Madison WI, September 27 2003, p.14.

Bergman PJ, Camps-Palau MA, McKnight JA, Leibman NF, Craft DM, Riviere I, Wulderk M, Charney SC, Farrelly J, Novosad CA, Ettinger S, Endicott, MM, Ireland L, Brenn S, Hohenhaus AE, Houghton AN, Perales M, Wolchok JD.   Development of a xenogeneic DNA vaccine program for canine malignant melanoma with prolongation of survival in dogs with loco-regionally controlled stage II-III disease. Veterinary Cancer Society 23 rd Annual Conference, Madison WI, September 27 2003, p. 40.